Semmelweis University (SU), the Ministry of Innovation and Technology (MIT) and Novartis Hungary have signed a “first of its kind” Memorandum of Understanding to drive innovation  and impact the entire health ecosystem in Hungary. The three pillars of the collaboration are: expand  access to and accelerate digitization of clinical research in Hungary, ensure  pathway to Hungarian leadership in cell and gene therapies,  and launch a “Cardiovascular Intervention Program” aimed at reaching 50k patients in the next 3 years, enabled by artificial intelligence and machine learning and focused on working together to bend the curve of CV disease in Hungary.

Press release